Dublin-based Icon, a provider of outsourced drug and device development and commercialisation services continues to expand. It is to acquire Nasdaq-listed PRA Health Sciences in a US$12bn deal. “The combined…
Dublin-based Icon, a provider of outsourced drug and device development and commercialisation services continues to expand. It is to acquire Nasdaq-listed PRA Health Sciences in a US$12bn deal. “The combined…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


